EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   3.4.21.93 | (2-Aminobenzoyl)-Lys-Glu-Arg-Ser-Lys-Arg-Ser-Ala-Leu-Arg-Asp-(3-nitro)Tyr-Ala + H2O |
- |
Homo sapiens |
(2-Aminobenzoyl)-Lys-Glu-Arg-Ser-Lys-Arg + Ser-Ala-Leu-Arg-Asp-(3-nitro)Tyr-Ala |
- |
? |
| 3.4.21.93 | Boc-Arg-Val-Arg-Arg-4-methyl-coumaryl-7-amide + H2O |
- |
Rattus norvegicus |
? |
- |
? |
| 3.4.21.93 | Cholecystokinin + H2O |
- |
Mus musculus |
? |
- |
? |
| 3.4.21.93 | cholecystokinin 8-containing peptide + H2O |
a synthetic peptide substrate containing the CCK 8 Gly Arg Arg peptide sequence, i.e. DYMGWMDF, and the cleavage site of pro-cholecystokinin for its liberation, overview |
Mus musculus |
? |
- |
? |
| 3.4.21.93 | dynorphin-A 1-17 + H2O |
- |
Mus musculus |
? |
- |
? |
| 3.4.21.93 | Glucagon + H2O |
- |
Mus musculus |
? |
- |
? |
| 3.4.21.93 | glucose-dependent insulinotropic polypeptide precursor + H2O |
PC1/3 is essential for pro-GIP processing |
Mus musculus |
glucose-dependent insulinotropic polypeptide + propeptide of glucose-dependent insulinotropic polypeptide |
GIP |
? |
| 3.4.21.93 | glucose-dependent insulinotropic polypeptide precursor + H2O |
i.e. pro-GIP, incretin hormone |
Mus musculus |
glucose-dependent insulinotropic polypeptide + propeptide of glucose-dependent insulinotropic polypeptide |
GIP |
? |
| 3.4.21.93 | L-pGlu-L-Arg-L-Thr-L-Lys-Arg-7-amido-4-methylcoumarin + H2O |
- |
Haliotis diversicolor supertexta |
L-pGlu-L-Arg-L-Thr-L-Lys-Arg + 7-amino-4-methylcoumarin |
- |
? |
| 3.4.21.93 | more |
unlike prohormone convertase 2, does not hydrolyze proluteinizing-hormone-releasing-hormone |
Mus musculus |
? |
- |
? |
